{"symbol":"SZ300015","secucode":"300015.SZ","items":[{"title":"交易金额约7亿元，爱尔眼科宣布并购巴西眼科龙头","summary":"6月10日晚间，爱尔眼科发布公告称，拟通过境外全资子公司AIERBrazil，向SF1125pParticipaesSocietáriasS.A.（简称“目标公司”）增资认购其新增股份。交易完成后，AIERBrazil将取得目标公司60.57%股权，并通过目标公司间接持有ClínicasdoBrasil的50.06%股权以及Contact-Gel60.57%股权。","source":null,"url":"http://finance.eastmoney.com/news/1354,202606103767043886.html","info_code":"NW202606103767043886","show_time_timestamp":1781100415000,"show_time":"2026-06-10 22:06:55","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202606103767043886.html","url":"http://finance.eastmoney.com/news/1354,202606103767043886.html","code":"202606103767043886","infoCode":"NW202606103767043886","recordId":null,"source":null,"title":"交易金额约7亿元，爱尔眼科宣布并购巴西眼科龙头","updateTime":0,"showDateTime":1781100415000,"publishDate":0,"sRatingName":null,"summary":"6月10日晚间，爱尔眼科发布公告称，拟通过境外全资子公司AIERBrazil，向SF1125pParticipaesSocietáriasS.A.（简称“目标公司”）增资认购其新增股份。交易完成后，AIERBrazil将取得目标公司60.57%股权，并通过目标公司间接持有ClínicasdoBrasil的50.06%股权以及Contact-Gel60.57%股权。"}},{"title":"拟并购巴西眼科龙头 爱尔眼科全球化版图扩至南美","summary":"爱尔眼科医院集团股份有限公司（以下简称“爱尔眼科”）发布公告称，拟通过境外全资子公司AIERBrazil，向SF1125pParticipaesSocietáriasS.A.（以下简称“目标公司”）增资认购其新增股份。","source":null,"url":"http://finance.eastmoney.com/news/1354,202606103767022465.html","info_code":"NW202606103767022465","show_time_timestamp":1781099100000,"show_time":"2026-06-10 21:45:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202606103767022465.html","url":"http://finance.eastmoney.com/news/1354,202606103767022465.html","code":"202606103767022465","infoCode":"NW202606103767022465","recordId":null,"source":null,"title":"拟并购巴西眼科龙头 爱尔眼科全球化版图扩至南美","updateTime":0,"showDateTime":1781099100000,"publishDate":0,"sRatingName":null,"summary":"爱尔眼科医院集团股份有限公司（以下简称“爱尔眼科”）发布公告称，拟通过境外全资子公司AIERBrazil，向SF1125pParticipaesSocietáriasS.A.（以下简称“目标公司”）增资认购其新增股份。"}},{"title":"爱尔眼科：第七届董事会第七次会议决议公告","summary":"证券日报网讯6月10日，爱尔眼科发布公告称，公司第七届董事会第七次会议审议通过《关于全资子公司通过认购增资方式收购巴西眼科医疗服务集团控制权的议案》。本次交易认购金额为5.30亿巴西雷亚尔，折合人民币约6.96亿元。","source":null,"url":"http://finance.eastmoney.com/news/1354,202606103767011672.html","info_code":"NW202606103767011672","show_time_timestamp":1781098740000,"show_time":"2026-06-10 21:39:00","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202606103767011672.html","url":"http://finance.eastmoney.com/news/1354,202606103767011672.html","code":"202606103767011672","infoCode":"NW202606103767011672","recordId":null,"source":null,"title":"爱尔眼科：第七届董事会第七次会议决议公告","updateTime":0,"showDateTime":1781098740000,"publishDate":0,"sRatingName":null,"summary":"证券日报网讯6月10日，爱尔眼科发布公告称，公司第七届董事会第七次会议审议通过《关于全资子公司通过认购增资方式收购巴西眼科医疗服务集团控制权的议案》。本次交易认购金额为5.30亿巴西雷亚尔，折合人民币约6.96亿元。"}},{"title":"全球化再落子！爱尔眼科拟约7亿元控股巴西最大眼科集团，后者亏损且无业绩承诺条款","summary":"6月10日晚间，爱尔眼科（300015）发布全资子公司通过认购增资方式收购巴西眼科医疗服务集团控制权的公告。本次交易认购金额为5.30亿巴西雷亚尔（BRL），折合人民币约6.96亿元。交易对应静态市销率1.04倍公开资料显示，爱尔眼科主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜服务，公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。","source":null,"url":"http://finance.eastmoney.com/news/1354,202606103766990011.html","info_code":"NW202606103766990011","show_time_timestamp":1781098036000,"show_time":"2026-06-10 21:27:16","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202606103766990011.html","url":"http://finance.eastmoney.com/news/1354,202606103766990011.html","code":"202606103766990011","infoCode":"NW202606103766990011","recordId":null,"source":null,"title":"全球化再落子！爱尔眼科拟约7亿元控股巴西最大眼科集团，后者亏损且无业绩承诺条款","updateTime":0,"showDateTime":1781098036000,"publishDate":0,"sRatingName":null,"summary":"6月10日晚间，爱尔眼科（300015）发布全资子公司通过认购增资方式收购巴西眼科医疗服务集团控制权的公告。本次交易认购金额为5.30亿巴西雷亚尔（BRL），折合人民币约6.96亿元。交易对应静态市销率1.04倍公开资料显示，爱尔眼科主营业务是各类眼科疾病诊疗、手术服务与医学验光配镜服务，公司的主要产品是屈光项目、白内障项目、眼前段项目、眼后段项目、视光服务项目。"}},{"title":"收购巴西最大眼科医疗集团 爱尔眼科7亿元出手加码全球化","summary":"上证报中国证券网讯（记者夏子航）全球眼科医疗连锁集团龙头企业——爱尔眼科出手了。最新公告显示，爱尔眼科拟通过全资子公司AIERBrazil出手，通过认购增资方式收购当地最大眼科医疗集团——巴西眼科医疗服务集团控制权，全面拓展拉丁美洲业务，加速全球化进程。爱尔眼科本次交易认购金额为5.30亿巴西雷亚尔（BRL），折合人民币约6.96亿元。近来，爱尔眼科动作频频。","source":null,"url":"http://finance.eastmoney.com/news/1354,202606103766938827.html","info_code":"NW202606103766938827","show_time_timestamp":1781097080000,"show_time":"2026-06-10 21:11:20","publish_time_timestamp":0,"publish_time":"","update_time_timestamp":0,"update_time":"","raw":{"uniqueUrl":"http://finance.eastmoney.com/a/202606103766938827.html","url":"http://finance.eastmoney.com/news/1354,202606103766938827.html","code":"202606103766938827","infoCode":"NW202606103766938827","recordId":null,"source":null,"title":"收购巴西最大眼科医疗集团 爱尔眼科7亿元出手加码全球化","updateTime":0,"showDateTime":1781097080000,"publishDate":0,"sRatingName":null,"summary":"上证报中国证券网讯（记者夏子航）全球眼科医疗连锁集团龙头企业——爱尔眼科出手了。最新公告显示，爱尔眼科拟通过全资子公司AIERBrazil出手，通过认购增资方式收购当地最大眼科医疗集团——巴西眼科医疗服务集团控制权，全面拓展拉丁美洲业务，加速全球化进程。爱尔眼科本次交易认购金额为5.30亿巴西雷亚尔（BRL），折合人民币约6.96亿元。近来，爱尔眼科动作频频。"}}]}